Cargando…
Stimulated Expression of CXCL12 in Adrenocortical Carcinoma by the PPARgamma Ligand Rosiglitazone Impairs Cancer Progression
Adrenocortical carcinoma (ACC) is a rare malignancy with poor prognosis when metastatic and scarce treatment options in the advanced stages. In solid tumors, the chemokine CXCL12/CXCR4 axis is involved in the metastatic process. We demonstrated that the human adrenocortex expressed CXCL12 and its co...
Autores principales: | Cantini, Giulia, Fei, Laura, Canu, Letizia, Lazzeri, Elena, Sottili, Mariangela, Francalanci, Michela, Angelotti, Maria Lucia, De Filpo, Giuseppina, Ercolino, Tonino, Gelmini, Stefania, Mangoni, Monica, Nesi, Gabriella, Hantel, Constanze, Mannelli, Massimo, Maggi, Mario, Luconi, Michaela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622353/ https://www.ncbi.nlm.nih.gov/pubmed/34834449 http://dx.doi.org/10.3390/jpm11111097 |
Ejemplares similares
-
Circulating Fascin 1 as a Promising Prognostic Marker in Adrenocortical Cancer
por: Cantini, Giulia, et al.
Publicado: (2021) -
Prognostic and Monitoring Value of Circulating Tumor Cells in Adrenocortical Carcinoma: A Preliminary Monocentric Study
por: Cantini, Giulia, et al.
Publicado: (2020) -
Rosiglitazone Inhibits Adrenocortical Cancer Cell Proliferation by Interfering with the IGF-IR Intracellular Signaling
por: Cantini, Giulia, et al.
Publicado: (2008) -
New insights in the clinical and translational relevance of miR483-5p in adrenocortical cancer
por: Salvianti, Francesca, et al.
Publicado: (2017) -
Carbonic anhydrases III and IX are new players in the crosstalk between adrenocortical carcinoma and its altered adipose microenvironment
por: Fei, L., et al.
Publicado: (2023)